» Authors » Maphoshane Nchabeleng

Maphoshane Nchabeleng

Explore the profile of Maphoshane Nchabeleng including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 700
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Garrett N, Tapley A, Hudson A, Dadabhai S, Zhang B, Mgodi N, et al.
EClinicalMedicine . 2025 Feb; 80:103054. PMID: 39902315
Background: With limited access to mRNA COVID-19 vaccines in lower income countries, and people living with HIV (PLWH) largely excluded from clinical trials, Part A of the multicentre CoVPN 3008...
2.
van den Bergh D, Charani E, Dramowski A, Annor A, Gijzelaar M, Messina A, et al.
JAC Antimicrob Resist . 2025 Jan; 7(1):dlae222. PMID: 39872681
Background: Research on the contextual drivers of antimicrobial stewardship (AMS) programme interventions in neonatal units is limited. Methods: As part of a prospective mixed-methods multidisciplinary neonatal AMS (NeoAMS) interventional study...
3.
Garrett N, Reddy T, Yende-Zuma N, Takalani A, Woeber K, Bodenstein A, et al.
PLOS Glob Public Health . 2024 Dec; 4(12):e0003260. PMID: 39636838
Limited studies have been conducted on the safety and effectiveness of heterologous COVID-19 vaccine boosting in lower income settings, especially those with high-HIV prevalence., The Sisonke Heterologous mRNA-1273 boost after...
4.
Ramashia M, Phofa T, Nkawane G, Nogbou N, Bolukaoto J, Nchabeleng M, et al.
Acta Microbiol Immunol Hung . 2023 Nov; 70(4):295-303. PMID: 37917156
This study aimed to investigate phenotypic and genotypic characteristics of carbapenem-resistant Enterobacterales isolates (CRE) at a tertiary laboratory in South Africa. A total of 99 CRE isolates were collected between...
5.
Mashingaidze R, Moodie Z, Allen M, Bekker L, Grove D, Grunenberg N, et al.
PLOS Glob Public Health . 2023 Apr; 3(4):e0001782. PMID: 37018240
There is limited data about bacterial STIs in MSM populations in sub-Saharan Africa. Our retrospective analysis used data from the HVTN 702 HIV vaccine clinical trial (October 2016 to July...
6.
Le Roux M, Ngwenya I, Nemarude A, De Villiers B, Mathebula M, Nchabeleng M
Int J STD AIDS . 2022 Dec; 34(3):183-190. PMID: 36542494
Background: Men having sex with men (MSM) are at increased risk of acquiring sexually transmitted infections (STIs), including extra-urethral infections. This study aimed to provide information on the presence of...
7.
Meiring S, Cohen C, de Gouveia L, du Plessis M, Quan V, Kleynhans J, et al.
Int J Infect Dis . 2022 Aug; 122:1056-1066. PMID: 35934172
Objectives: Providing country-specific estimates of case fatality and sequelae from bacterial meningitis (BM) is important to evaluate and monitor progress toward the World Health Organization's roadmap to "defeating meningitis by...
8.
Moodie Z, Dintwe O, Sawant S, Grove D, Huang Y, Janes H, et al.
J Infect Dis . 2022 Jun; 226(2):246-257. PMID: 35758878
Background: The ALVAC/gp120 + MF59 vaccines in the HIV Vaccine Trials Network (HVTN) 702 efficacy trial did not prevent human immunodeficiency virus-1 (HIV-1) acquisition. Vaccine-matched immunological endpoints that were correlates...
9.
Lawal I, Mokoala K, Mathebula M, Moagi I, Popoola G, Moeketsi N, et al.
Front Med (Lausanne) . 2022 Mar; 9:791653. PMID: 35295606
Patients who complete a standard course of anti-tuberculous treatment (ATT) for pulmonary tuberculosis and are declared cured according to the current standard of care commonly have residual metabolic activity (RMA)...
10.
Mistry H, Lebelo R, Matshonyonge F, Nchabeleng M, Mathebula M, Bogers J, et al.
AIMS Public Health . 2022 Jan; 9(1):129-141. PMID: 35071673
Data lag is evident when observing studies focussing on human papillomavirus (HPV) prevalence in the head and neck of men who have sex with men (MSM) in Southern Africa. Sexual...